1-5 of 5
Jeffery L. Kutok, M.D.
Close
Sort by
Journal Articles

Tonic B-Cell Receptor Signaling Promotes the Survival of Diffuse Large B-Cell Lymphomas: Identification of SYK as a Rational Treatment Target.

Linfeng Chen, PhD, Przemyslaw Juszczynski, M.D., Ph.D., Yasumichi Hitoshi, Ph.D., Wen Chen, M.D., Jeffery L. Kutok, M.D., Margaret A. Shipp, M.D.
Journal: Blood
Blood (2006) 108 (11): 226.
https://doi.org/10.1182/blood.V108.11.226.226
Published: 2006
Journal Articles

Inducible hkRASG12D Expression in Zebrafish Hematopoietic Cells Leads to Myeloproliferative Disease.

Xiuning Le, David M. Langenau, Ph.D., Matthew D. Keefe, Jeffery L. Kutok, M.D. Ph.D., Leonard I. Zon, M.D.
Journal: Blood
Blood (2006) 108 (11): 2691.
https://doi.org/10.1182/blood.V108.11.2691.2691
Published: 2006
Journal Articles

PKC412 Effectively Inhibits Constitutively Activated FGFR3 Mutants in Murine Leukemia Models and t(4;14) Myeloma Cell Lines.

Jing Chen, Ph.D., Benjamin H. Lee, M.D., Ph.D., Ifor R. Williams, M.D., Ph.D., Jeffery L. Kutok, M.D., Ph.D., Nicole Duclos, Sarah Cohen, Jennifer Adelsperger, Rachel Okabe, Allison Coburn, Sandra Moore, Brian J.P. Huntly, M.D., Ph.D., Constantine S. Mitsiades, M.D., Kenneth C. Anderson, M.D., James D. Griffin, M.D., Doriano Fabbro, Ph.D., D. Gary Gilliland, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2448.
https://doi.org/10.1182/blood.V104.11.2448.2448
Published: 2004
Journal Articles

PKC412 Inhibits the ZNF198-FGFR1 Fusion Tyrosine Kinase and Is Efficacious in Treatment of t(8;13)(p11;q12) Associated Stem Cell Myeloproliferative Disease.

Jing Chen, Ph.D., Daniel J. DeAngelo, M.D., Jeffery L. Kutok, M.D., Ph.D., Ifor R. Williams, M.D., Ph.D., Benjamin H. Lee, M.D., Ph.D., Martha Wadleigh, M.D., Nicole Duclos, Sarah Cohen, Jennifer Adelsperger, Rachel Okabe, Allison Coburn, Ilene Galinsky, Brian J.P. Huntly, M.D., Ph.D., Pamela Cohen, Ph.D., Thomas Meyer, Ph.D., Doriano Fabbro, Ph.D., Lolita Banerji, Ph.D., James D. Griffin, M.D., Sheng Xiao, M.D., Jonathan A. Fletcher, M.D., Richard M. Stone, M.D., D. Gary Gilliland, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2549.
https://doi.org/10.1182/blood.V104.11.2549.2549
Published: 2004
Journal Articles

Mechanism of Oncogenesis by Leukemia-Associated Mutants of Shp2 (PTPN11).

M. Golam Mohi, Ph.D, Heike Keilhack, Ph.D., Sarah Cohen, Christina Boulton, Toshiyuki Araki, Ph.D., Ifor Williams, M.D., Ph.D., Jeffery L. Kutok, M.D., Ph.D., D. Gary Gilliland, M.D., Ph.D., Benjamin G. Neel, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 199.
https://doi.org/10.1182/blood.V104.11.199.199
Published: 2004